REV-ERBα抑制破骨细胞生成并保护牙槽骨丢失
本研究通过机器学习建立牙周炎昼夜节律评分模型,发现核心时钟基因NR1D1(编码REV-ERBα)在牙周炎中异常表达。小鼠实验证实昼夜节律紊乱改变REV-ERBα表达,激动剂SR9009可抑制RANKL诱导的破骨分化并减轻牙槽骨丢失,机制涉及IL-22-STAT3通路抑制REV-ERBα。
要点
- NR1D1/REV-ERBα是昼夜节律紊乱影响牙周炎的关键因子。
- SR9009激活REV-ERBα可抑制破骨细胞分化并减少牙槽骨丢失。
- IL-22-STAT3通路抑制REV-ERBα表达并调控破骨分化。
核心结论
- REV-ERBα在破骨细胞生成中起抑制作用,激活REV-ERBα可减轻牙周炎相关牙槽骨吸收。
研究设计与样本
- 利用GEO数据库牙周炎临床队列转录组数据通过机器学习建立PeriCRS模型。
- 小鼠牙周结扎模型采用每2天提前6小时的LD12:12周期建立昼夜节律紊乱。
主要发现
- 生物信息学分析显示NR1D1是昼夜节律紊乱影响牙周炎的关键因子。
- 小鼠炎症牙周组织中Rev-erbα表达异常,昼夜节律紊乱改变REV-ERBα表达。
- SR9009激活REV-ERBα显著减少RANKL诱导的破骨细胞分化并抑制破骨相关因子表达。
- 体内实验显示SR9009减轻牙周炎所致牙槽骨丢失。
- 体外实验发现IL-22-STAT3通路抑制REV-ERBα表达并调控RANKL诱导的破骨分化。
关键数值与推荐
- PeriCRS模型基于GEO数据库牙周炎临床队列转录组数据建立。
- 小鼠昼夜节律紊乱模型为每2天提前6小时的光照周期(LD12:12)。
临床怎么用
- 提示REV-ERBα激动剂SR9009可能成为牙周炎牙槽骨吸收的潜在治疗方向。
- 临床关注牙周炎患者昼夜节律紊乱对骨吸收的影响可能具有意义。
局限性
- 原文未报告研究样本量、P值及置信区间等具体统计数值。
- 机制结论主要基于小鼠模型和体外实验,尚未在临床人群中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Circadian rhythm disruption is thought to be associated with periodontitis, and molecular clock genes play critical roles in regulating bone homeostasis. However, the specific contribution of molecular clock genes to alveolar bone resorption caused by periodontitis is poorly understood. In this study, we introduced a novel Periodontitis Circadian Rhythm Score (PeriCRS) model that was established through machine learning using periodontal transcriptomic data from periodontitis clinical cohorts in the Gene Expression Omnibus (GEO) database. This approach revealed the potential regulatory role of circadian rhythm disruption in periodontitis and identified key molecular clock genes associated with alveolar bone destruction. Moreover, we established an experimental periodontitis model with circadian rhythm disturbance via periodontal ligation in mice exposed to a 6-h advanced LD12:12 cycle every 2 d. Our bioinformatics analysis revealed that NR1D1, which encodes REV-ERBα, is a pivotal factor in the impact of circadian rhythm disruption on periodontitis in periodontal tissues. Next, we confirmed the abnormal expression of the molecular clock gene Rev-erbα in inflammatory periodontal tissue in mice and confirmed that circadian rhythm disruption altered REV-ERBα expression. Furthermore, the activation of REV-ERBα with the agonist SR9009 notably decreased RANKL-induced osteoclast differentiation and suppressed the expression of osteoclast-related factors. Subsequent in vivo experiments demonstrated that SR9009 mitigated alveolar bone loss caused by periodontitis. Mechanistically, we found that the IL-22-STAT3 pathway inhibited REV-ERBα expression and modulated RANKL-induced osteoclast differentiation in vitro. Our results elucidate the role of REV-ERBα in osteoclastogenesis and suggest a potential new therapeutic avenue for addressing alveolar bone resorption associated with periodontitis.
引用
- Zhang C, Tan L, Li J, et al. REV-ERBα Inhibits Osteoclastogenesis and Protects against Alveolar Bone Loss. J Dent Res. 2024. PMID: 39629951. doi:10.1177/00220345241290444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。